ArticleClinicoEconomics and outcomes research : CEOR2021

Clinical Outcomes, Costs, and Healthcare Resource Utilization in Patients with Metastatic Merkel Cell Carcinoma Treated with Immune Checkpoint Inhibitors vs Chemotherapy.

Ying Zheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.